Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

Lipid metabolism derangement contributes to increased cardiovascular risk in Rheumatoid Arthritis (RA). It is still debated whether and how tocilizumab, an interleukin-6 receptor inhibitor used in active RA, impacts cardiovascular risk. We studied the effect of tocilizumab on the regulation of macro...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Daniela, Gualtierotti, Roberta, Agosti, Pasquale, Adorni, Maria Pia, Ingegnoli, Francesca, Rota, Matteo, Bernini, Franco, Meroni, Pier Luigi, Ronda, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408911/
https://www.ncbi.nlm.nih.gov/pubmed/32650513
http://dx.doi.org/10.3390/jcm9072157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408911/
https://www.ncbi.nlm.nih.gov/pubmed/32650513
http://dx.doi.org/10.3390/jcm9072157

Ejemplares similares